Dave is a business and technology strategist for the pharmaceutical and healthcare industry. Prior to founding healtheo360, David founded New Colony Partners and MedTera. David has served as general manager for three pharmaceutical marketing services companies: Clark-O’Neill, Physician Desk Reference and Phoenix Marketing Group in developing solutions which contribute to enriching, prolonging and savings people’s lives. David is also the founder of eHealthScience.com, an online data reporting and insights company providing marketing intelligence to the Healthcare, Life Science and Pharmaceutical industry.
Robert is a very successful change and transformation leader in a number of sales and marketing driven industries, a highly experienced outside director of public and private companies and personal investor. From 1988 until 1999, Robert served as Chairman and Chief Executive Officer of ADVO, Inc., the nation’s largest direct mail microtargeting services company with $1 billion in annual revenue (NYSE). He has also served as CEO of DIMAC, Inc., RKO/Six Flags Entertainment, Inc., and Max Factor, Inc. Robert is currently on the Board of Directors of MDC Partners, Inc. (NASDAQ and TSE) along with several private companies. He has previously served on a number of public boards including RadioShack (NYSE), Linens n Things (NYSE), Vertrue, Inc. (NASDAQ), IMS Health (NYSE), R. H. Donnelley (NYSE) and Playboy Enterprises (NYSE) among others.
John graduated from Central Michigan University in 1983 with a B.S. in chemistry, mathematics and computer science. He graduated from the University of California, Berkeley in 1988 with a Ph.D. in synthetic organic and computational chemistry. In 2011, he joined R-Squared Services & Solutions in a principle officer position as Chief Software Architect. R-Squared was a leading software company that provided healthcare and life sciences companies with powerful ways to assure compliance with the web of laws and regulations affecting them. His role was to assist in the development of RADS® compliance platform and to develop the CIR2US® system for customer master/master data management, itemized expenses and high-speed searching which comprised the backend for all the R-Squared’s applications.
Dave is an environmental consultant who has been providing environmental liability analysis for corporations across North America. His primary practice area has focused on re-positioning of an environmentally impaired real estate and working with global companies to improve their environmental footprint for long-term growth and sustainability.
Mike’s entire career has been focused on the intersection of healthcare and technology, where most recently, he co-founded and served as President and CEO of R-Squared Services & Solutions, Inc. (now part of QunitilesIMS), which was a SAAS-based compliance software provider to the pharmaceutical and medical device industries. Prior to that, Michael was a partner at a prestigious Washington, DC law firm where he advised players across the US healthcare sector.
Robert is President / Owner of Drug and Biotechnology Development LLC, a consultancy to the pharmaceutical industry and academia for biological, drug and device development. Dr. Bell received his B.S. in Chemistry, M.S. in Food Science and Human Nutrition and Ph.D. in Pharmaceutics from the University of Florida. Research interests include pharmaceutical and biomedical analysis, CMC, quality, vaccines, biosimilar proteins, women’s health products, oncology therapeutics, drug addiction treatment and green pharmaceutical chemistry initiatives.
Leslie Norwalk is Strategic Counsel to Epstein Becker Green, P.C., EBG Advisors and National Health Advisors. She serves as an advisor to three private equity firms: Warburg Pincus, Peloton Equity, and Enhanced Equity Fund; and currently sits on the boards of directors of NuVasive, Endologix, Providence Service Corp., Cedar Gate, Abode Healthcare, HPOne, Linkwell Health and MedCircle. Ms. Norwalk served the Bush Administration as the Acting Administrator for the Centers for Medicare & Medicaid Services (CMS). She managed the day-to-day operations of Medicare, Medicaid, State Child Health Insurance Programs, Survey and Certification of health care facilities and other federal health care initiatives. Ms. Norwalk, a native of Dayton, OH, earned a juris doctor degree from the George Mason University School of Law, where she was a Dean’s Scholar and an editor of the George Mason Law Review. She earned a bachelor’s degree, cum laude, in economics and international relations from Wellesley College.
David B. Nash is the Founding Dean Emeritus and the Dr. Raymond C. and Doris N. Grandon Professor of Health Policy at the Jefferson College of Population Health (JCPH). A board-certified internist, Dr. Nash is internationally recognized for his work in public accountability for outcomes, physician leadership development, and quality-of-care improvement. Repeatedly named to Modern Healthcare’s list of Most Powerful Persons in Healthcare, his national activities cover a wide scope. In the for-profit sector, he very recently completed nearly a decade as a member of the Board of Directors for Humana, Inc., one of the nation’s largest publicly traded healthcare companies. Dr. Nash received his BA in economics (Phi Beta Kappa) from Vassar College; his MD from the University of Rochester School of Medicine and Dentistry and his MBA in Health Administration (with honors) from the Wharton School at the University of Pennsylvania.
Read More on David Nash
As a business and operations strategist for the healthcare industry and former president of Cardiac Rhythm Associates of New Jersey, Tim has focused his career on developing solutions designed to support patients and caregivers. Prior to joining Cardiac Rhythm Associates, Tim served as a Territory Manager and Consultant for Guidant, which was acquired by Boston Scientific and St. Jude Medical in their Cardiac Units. Tim started his sales and marketing career with Merck where he launched numerous products. Tim earned his B.S. in Accounting from LaSalle University and an M.S. and M.B.A. from the New Jersey Institute of Technology.
With over 20 years of experience, Greg has devoted his career to leveraging innovative digital technologies, driving value-based solutions and measuring return on investment. Starting his career with Wyeth Pharmaceutical (now Pfizer), and then leading digital transformation with Reed Elsevier, Greg has since worked across point of care, HCP, and Managed Markets. His most recent work has been focused on driving adherence by helping to enhance patient support strategies through the use of evidence-based health psychology models.